Abnormally elevated CD38 expression in T‐ALL and T‐LBL is associated with tumor expansion and progressive disease, making CD38 a potential target for anti‐T‐ALL and T‐LBL treatment.6, 7. The gene discussed is CD38; the disease is neoplasm.